NASDAQ: CLLSCellectis Sa Stock Ownership - Who owns Cellectis Sa?
Insider buying vs selling
Have Cellectis Sa insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CLLS insiders and whales buy or sell their stock.
CLLS Shareholders
What type of owners hold Cellectis Sa stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| B Group Inc | 4.52% | 3,281,501 | $9.09M | Institution |
| Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC | 4.38% | 3,178,620 | $8.80M | Institution |
| Long Focus Capital Management LLC | 3.78% | 2,744,098 | $7.60M | Institution |
| Blackrock Inc | 0.47% | 341,523 | $946.02k | Institution |
| Nomura Asset Management International Inc | 0.31% | 226,875 | $628.44k | Institution |
| Morgan Stanley | 0.12% | 86,776 | $240.37k | Institution |
| Lpl Financial LLC | 0.12% | 84,345 | $233.64k | Institution |
| Susquehanna International Group LLP | 0.09% | 65,942 | $182.66k | Institution |
| Citadel Advisors LLC | 0.06% | 44,315 | $122.75k | Institution |
| Marshall Wace LLP | 0.06% | 41,112 | $113.88k | Institution |
CLLS vs Biotech Stocks
Cellectis Sa Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.